Your browser doesn't support javascript.
loading
Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study.
Passaes, Caroline; Millet, Antoine; Madelain, Vincent; Monceaux, Valérie; David, Annie; Versmisse, Pierre; Sylla, Naya; Gostick, Emma; Llewellyn-Lacey, Sian; Price, David A; Blancher, Antoine; Dereuddre-Bosquet, Nathalie; Desjardins, Delphine; Pancino, Gianfranco; Le Grand, Roger; Lambotte, Olivier; Müller-Trutwin, Michaela; Rouzioux, Christine; Guedj, Jérémie; Avettand-Fenoel, Véronique; Vaslin, Bruno; Sáez-Cirión, Asier.
Afiliación
  • Passaes C; Institut Pasteur, HIV Inflammation and Persistence, Paris, France; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.
  • Millet A; Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA 7327 Paris, France.
  • Madelain V; Université Paris-Diderot, IAME, INSERM UMR 1137, Sorbonne Paris Cité, Paris, France.
  • Monceaux V; Institut Pasteur, HIV Inflammation and Persistence, Paris, France.
  • David A; Institut Pasteur, HIV Inflammation and Persistence, Paris, France.
  • Versmisse P; Institut Pasteur, HIV Inflammation and Persistence, Paris, France.
  • Sylla N; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.
  • Gostick E; Cardiff University School of Medicine, Division of Infection and Immunity, Cardiff, UK.
  • Llewellyn-Lacey S; Cardiff University School of Medicine, Division of Infection and Immunity, Cardiff, UK.
  • Price DA; Cardiff University School of Medicine, Division of Infection and Immunity, Cardiff, UK.
  • Blancher A; Université Paul Sabatier, Laboratoire d'Immunogénétique Moléculaire, EA 3034 Toulouse, France; CHU de Toulouse, Laboratoire d'Immunologie, Toulouse, France.
  • Dereuddre-Bosquet N; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.
  • Desjardins D; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.
  • Pancino G; Institut Pasteur, HIV Inflammation and Persistence, Paris, France.
  • Le Grand R; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.
  • Lambotte O; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France; Assistance Publique-Hôpitaux de Paris, Service de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Université
  • Müller-Trutwin M; Institut Pasteur, HIV Inflammation and Persistence, Paris, France.
  • Rouzioux C; Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA 7327 Paris, France; Assistance Publique-Hôpitaux de Paris, Service de Microbiologie Clinique, Hôpital Necker-Enfants Malades, Paris, France.
  • Guedj J; Université Paris-Diderot, IAME, INSERM UMR 1137, Sorbonne Paris Cité, Paris, France.
  • Avettand-Fenoel V; Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA 7327 Paris, France; Assistance Publique-Hôpitaux de Paris, Service de Microbiologie Clinique, Hôpital Necker-Enfants Malades, Paris, France.
  • Vaslin B; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France. Electronic address: bruno.vaslin@cea.fr.
  • Sáez-Cirión A; Institut Pasteur, HIV Inflammation and Persistence, Paris, France. Electronic address: asier.saez-cirion@pasteur.fr.
Cell Rep ; 32(12): 108174, 2020 09 22.
Article en En | MEDLINE | ID: mdl-32966788
ABSTRACT
Highly efficient CD8+ T cells are associated with natural HIV control, but it has remained unclear how these cells are generated and maintained. We have used a macaque model of spontaneous SIVmac251 control to monitor the development of efficient CD8+ T cell responses. Our results show that SIV-specific CD8+ T cells emerge during primary infection in all animals. The ability of CD8+ T cells to suppress SIV is suboptimal in the acute phase but increases progressively in controller macaques before the establishment of sustained low-level viremia. Controller macaques develop optimal memory-like SIV-specific CD8+ T cells early after infection. In contrast, a persistently skewed differentiation phenotype characterizes memory SIV-specific CD8+ T cells in non-controller macaques. Accordingly, the phenotype of SIV-specific CD8+ T cells defined early after infection appears to favor the development of protective immunity in controllers, whereas SIV-specific CD8+ T cells in non-controllers fail to gain antiviral potency, feasibly as a consequence of early defects imprinted in the memory pool.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Inmunodeficiencia Adquirida del Simio / Virus de la Inmunodeficiencia de los Simios / Linfocitos T CD8-positivos Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Cell Rep Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Inmunodeficiencia Adquirida del Simio / Virus de la Inmunodeficiencia de los Simios / Linfocitos T CD8-positivos Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Cell Rep Año: 2020 Tipo del documento: Article País de afiliación: Francia